BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pediatric Endocrine Society - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pediatric Endocrine Society
X-ORIGINAL-URL:https://pedsendo.org
X-WR-CALDESC:Events for Pediatric Endocrine Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240723T193000
DTEND;TZID=America/New_York:20240723T203000
DTSTAMP:20240613T161631Z
CREATED:20240522T162430Z
LAST-MODIFIED:20240613T161631Z
UID:23930-1721763000-1721766600@pedsendo.org
SUMMARY:PES Podcast Club\, hosted by EDI Committee
DESCRIPTION:Podcast Club: July 23rd at 7:30 PM EST \nFeaturing “Remembering and Unremembering\, from Kigali to Nashville” from NPR’s Code Switch\, also available on Apple Podcasts. \nRemembering and unremembering\, from Kigali to Nashville : Code Switch : NPR \n  \nRegister Here
URL:https://pedsendo.org/event/pes-podcast-club-hosted-by-edi-committee/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240718T173000
DTEND;TZID=America/New_York:20240718T184500
DTSTAMP:20240626T130726Z
CREATED:20240612T194336Z
LAST-MODIFIED:20240626T130726Z
UID:24094-1721323800-1721328300@pedsendo.org
SUMMARY:State of the Art Webinar hosted by: Ethics SIG
DESCRIPTION:Session Title: Medically Possible\, Not Medically Necessary: Case-Based Discussion of Ethical Questions in Pediatric Endocrinology \nBrief Description \nPES members are invited to submit de-identified pediatric endocrinology cases that raise ethical questions. Minimal preparation is required. If your case is selected\, you would be invited to present the case and the PES Ethics SIG will facilitate a guided discussion of the ethical issues that it raises. \nCases should touch on the following theme: Medically Possible\, Not Medically Necessary. \nCases should be submitted to camilia_kamoun@med.unc.edu by July 8\, 2024. \nIf you are interested but cannot attend at this time\, we would still like to hear from you. \n Learning Objectives  \n\nIdentify ethical dilemmas in pediatric endocrinology\nDescribe ethical approaches to clinical care in pediatric endocrinology\nDefine key ethical principles to guide clinical care in pediatric endocrinology\n\n  \nSpeaker Name \nCamilia Kamoun\, MD\, MSME* (she/her) \nClinical Assistant Professor of Pediatrics \nDivision of Pediatric Endocrinology \nUniversity of North Carolina School of Medicine
URL:https://pedsendo.org/event/state-of-the-art-webinar-hosted-by-ethics-sig/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240715T160000
DTEND;TZID=America/New_York:20240715T170000
DTSTAMP:20240814T192418Z
CREATED:20240612T193640Z
LAST-MODIFIED:20240814T192418Z
UID:24090-1721059200-1721062800@pedsendo.org
SUMMARY:PES Quarterly Education Committee Webinar
DESCRIPTION:Session Title: Challenges in the diagnosis and treatment of short stature attributed to GH deficiency \nBrief Description: Discussion regarding the diagnosis and treatment of growth hormone deficiency. \nLearning objectives: \n\nExplain why Growth hormone stimulation testing is of diagnostic value in a subset of children\nExplain why GST+ clinical history reveals a diagnostic continuum\nExplain why erroneous GHD in late childhood can be limited/corrected with pre-pubertal sex-hormone priming/pubertal GH discontinuation\n\nSpeaker: \nDavid Allen\, MD \nProfessor of Pediatrics \nUniversity of Wisconsin School of Medicine and Public Health \nHead of Division of Diabetes and Endocrinology \nDirector\, Diabetes/Endocrinology Fellowship \nUW American Family Children’s Hospital-Madison \n  \nView Recording
URL:https://pedsendo.org/event/pes-quarterly-education-committee-webinar/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240613T130000
DTEND;TZID=America/New_York:20240613T140000
DTSTAMP:20240522T172305Z
CREATED:20240522T172210Z
LAST-MODIFIED:20240522T172305Z
UID:23938-1718283600-1718287200@pedsendo.org
SUMMARY:PES SEED Webinar: Pediatric Thyroid Disease
DESCRIPTION:Thursday\, June 13\, 2024 \n1:00 PM EST \nBrief Description \nThis lecture will cover a range of topics\, including the anatomy and function of the thyroid gland in children\, common thyroid disorders seen in pediatric patients\, diagnostic methods such as blood tests and imaging studies\, and treatment options including medication\, surgery\, and radioactive iodine therapy. We will discuss the importance of early detection and management of thyroid disorders in children to prevent complications such as growth delays\, developmental delays\, and metabolic disturbances. \nLearning Objectives  \n\nReview thyroid hormone synthesis​\nUnderstand the most common causes of thyroid disease in infants and children and its management​\nUnderstand when to screen for thyroid disease​\n\n Speaker  \nDoris Fadoju\, MD \nAssociate Professor of Pediatrics \nEmory University School of Medicine \nChildren’s Healthcare of Atlanta \n  \n 
URL:https://pedsendo.org/event/pes-seed-webinar-pediatric-thyroid-disease/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240502
DTEND;VALUE=DATE:20240506
DTSTAMP:20240328T154531Z
CREATED:20240328T154531Z
LAST-MODIFIED:20240328T154531Z
UID:23731-1714608000-1714953599@pedsendo.org
SUMMARY:PES Annual Meeting
DESCRIPTION:The Pediatric Endocrine Society’s Annual Meeting brings together our diverse international community of over 1\,000 clinicians\, researchers\, and trainees to share the excitement of new ideas\, establish new friendships\, and learn the latest insights covering the wide scope of our diverse field. We invite you to be part of this in 2024!
URL:https://pedsendo.org/event/pes-annual-meeting/
ATTACH;FMTTYPE=image/jpeg:https://pedsendo.org/wp-content/uploads/2023/09/PES-Final-AM-Doc-Logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240405T130000
DTEND;TZID=America/New_York:20240405T140000
DTSTAMP:20240408T140450Z
CREATED:20240227T213502Z
LAST-MODIFIED:20240408T140450Z
UID:23601-1712322000-1712325600@pedsendo.org
SUMMARY:Competency-Based Medical Education and Entrustable Professional Activities in Pediatric Endocrinology
DESCRIPTION:Friday\, April 5\, 2024 \n01:00 pm – 2:00 pm EST \nSession Title: ABP Talk \nBrief Description: Competency-Based Medical Education and Entrustable Professional Activities in Pediatric Endocrinology \nLearning Objectives: \n1. Define competency-based medical education (CBME) and Entrustable Professional Activities (EPAs) \n2. Discuss the role of CBME and EPAs in improving education and assessment to advance child health in pediatric endocrinology \n3. Describe concrete examples of how to integrate the principles of CBME\, including EPAs\, into a pediatric endocrinology fellowship program \nSpeaker: \nDavid A. Turner\, MD \nVice President\, Competency-Based Medical Education \nAmerican Board of Pediatrics \n  \nLaura C. Page\, MD \nAssociate Professor of Pediatrics \nDuke University School of Medicine \nView Recording
URL:https://pedsendo.org/event/abp-talk/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240403T170000
DTEND;TZID=America/New_York:20240403T180000
DTSTAMP:20240404T144621Z
CREATED:20240226T201749Z
LAST-MODIFIED:20240404T144621Z
UID:23595-1712163600-1712167200@pedsendo.org
SUMMARY:Genetics of Turner syndrome: Beyond the classic 45\, X
DESCRIPTION:Wednesday\, April 3\, 2024\, 5:00 PM EST \nSession Type SIG: State of the Art: Turner syndrome SIG \nSession Title Genetics of Turner syndrome: Beyond the classic 45\, X \nBrief Description \nThe webinar will provide a brief overview of the current genetic landscape of Turner syndrome with a focus on the clinical utility of different genetic tests and interpretations for the endocrine clinician. \n  \nLearning Objectives  \n\nDiscuss the new genetic guidelines for what meets the criteria for Turner syndrome (TS) and address the incidental diagnosis of TS\nDiscuss the possibility of neonatal screening\, the current utility of NIPT\, and the role of different genetic testing modalities (karyotype\, FISH\, microarray\, WGS\, etc) in TS.\nReview mosaic TS and counseling re: low-level mosaicism\, known genotype/phenotype correlations in TS\, and co-occurrence of other genetic conditions with TS.\n\n  \nSpeaker Name \nMelissa L. Crenshaw\, M.D.\, FAAP\, FACMG \nAssistant Professor\, \nPediatrics Johns Hopkins University School of Medicine Director\, \nMedical Genetics Services Chief\, \nDivision of Genetics Johns Hopkins All Children’s Hospital \nView Recording
URL:https://pedsendo.org/event/genetics-of-turner-syndrome-beyond-the-classic-45-x/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240328T190000
DTEND;TZID=America/New_York:20240328T200000
DTSTAMP:20240402T163211Z
CREATED:20240226T200314Z
LAST-MODIFIED:20240402T163211Z
UID:23592-1711652400-1711656000@pedsendo.org
SUMMARY:Lipid SIG Webinar: Kids and Cholesterol: Challenges from Screening to Treatment
DESCRIPTION:Thursday\, March 28\, 2024\, 7:00 PM EST \nSession Type SIG: State of the Art: Lipid SIG \nSession Title Kids and Cholesterol: Challenges from Screening to Treatment. \n Brief Description \nOur speaker will give a PES webinar regarding challenges in pediatric lipid management. \nLearning Objectives  \n\nTo identify the clinical challenges in lipid management in pediatrics\nTo review the guidelines for lipid management in pediatrics\nTo discuss a practical approach to lipid management in pediatrics\n\nSpeaker Name \nAnne Carol Goldberg\, MD\, \nFACP Professor of Medicine Washington University School of Medicine \n 
URL:https://pedsendo.org/event/lipid-sig-webinar-kids-and-cholesterol-challenges-from-screening-to-treatment/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240327T120000
DTEND;TZID=America/New_York:20240327T130000
DTSTAMP:20240327T185523Z
CREATED:20240222T185113Z
LAST-MODIFIED:20240327T185523Z
UID:23581-1711540800-1711544400@pedsendo.org
SUMMARY:PES EDI Webinar: Disparities in Diabetes Technology: An Evidence-based Roadmap to Equity
DESCRIPTION:Wednesday\, March 27\, 2024\, 12:00 PM EST\nSession Type SIG: State of the Art: EDI \nSession Title Disparities in Diabetes Technology: An Evidence-based Roadmap to Equity \nBrief Description \nIn this webinar\, we will discuss multi-factorial drivers of disparities in pediatric type 1 diabetes with specific focus on the role of diabetes technology utilization. We will cover evidence-based solutions to address disparities relevant to clinicians and researchers alike. We will also discuss emerging technology disparities and system-level solutions to mitigate new disparities. \nLearning Objectives  \n\nRecognize diabetes technology as a modifiable risk factor in type 1 diabetes and identify populations at risk of inequitable diabetes care.\nIllustrate how diabetes technology is underutilized in minoritized populations and is subject inequity.\nRecognize ways to identify and mitigate inequities in diabetes technology use.\n\n  \nSpeaker Name \nAnanta Addala\, DO\, MPH \nAssistant Professor of Pediatrics at Stanford University \n  \nView Recording
URL:https://pedsendo.org/event/pes-edi-webinar-disparities-in-diabetes-technology-an-evidence-based-roadmap-to-equity/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240322T160000
DTEND;TZID=America/New_York:20240322T170000
DTSTAMP:20240322T130642Z
CREATED:20240320T145824Z
LAST-MODIFIED:20240322T130642Z
UID:23667-1711123200-1711126800@pedsendo.org
SUMMARY:State of the Art - Transgender Health SIG and Ethics SIG
DESCRIPTION:Title: Neurodiversity in Gender Dysphoria\n \nDescription:  \nNeurodiverse young people are more likely than neurotypical people to be gender diverse and gender diverse individuals are more likely to be neurodiverse than cisgender people. This presentation will review the current research in these intersecting areas and provide some tips for best clinical practices. \nLearning Objectives \n\n\nLearn about autism as a form of human neurodiversity\, including common thinking styles in autism and related diagnoses\n\n\nConsider how autism can impact clinical interactions with patients\, and how providers can employ “universal design” approaches to supporting the variety of communication and thinking styles of the patients\n\n\nReview existing (limited) research on common autistic gender-diverse phenotypes\, including existing adult outcomes data and profiles of autism-related needs.\n\n\nSpeaker: \nJohn Strang\, Psy.D. \nPediatric Neuropsychologist at Children’s National Hospital and Director of the Gender and Autism Program \nModerators: Dr. Janet Lee\, Dr. Hayley Baines\, Dr. Stephanie Roberts \nRegister Here
URL:https://pedsendo.org/event/state-of-the-art-transgender-health-sig-and-ethics-sig/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240319T150000
DTEND;TZID=America/New_York:20240319T170000
DTSTAMP:20240229T150008Z
CREATED:20240222T171759Z
LAST-MODIFIED:20240229T150008Z
UID:23578-1710860400-1710867600@pedsendo.org
SUMMARY:PedsENDO365 Webinar: Pediatric Bone Disorders
DESCRIPTION:Session Title Pediatric Bone Disorders \nBrief Description \nThe goal of this session is to increase fellow’s understanding of pathophysiology\, diagnostic tools\, and therapeutic options of various pediatric bone disorders\, including primary bone disorders such as rickets and osteogenesis imperfecta and secondary causes of osteoporosis. \nLearning Objectives  \n\nUnderstand pathophysiology and different subtypes of rickets\nReview the diagnostic evaluation of pediatric bone fragility\nUnderstand the management and treatment options\, including emerging pharmacologic therapies\, of pediatric osteoporosis\n\nSpeakers: \nMonica Grover\, MD\nJennifer Miller\, MD\nMalinda Wu\, MD\nAmbika Ashraf\, MD
URL:https://pedsendo.org/event/pedsendo365-webinar-pediatric-bone-disorders/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240318T160000
DTEND;TZID=America/New_York:20240318T170000
DTSTAMP:20240222T172043Z
CREATED:20240222T171301Z
LAST-MODIFIED:20240222T172043Z
UID:23575-1710777600-1710781200@pedsendo.org
SUMMARY:Quarterly Education Webinar: State of Immunotherapy in Type 1 Diabetes
DESCRIPTION:Session Title: State of Immunotherapy in Type 1 Diabetes \nBrief Description: This talk will discuss immunotherapy and its utility in Type 1 diabetes. \n  \nLearning objectives: \n\nIdentify mechanisms of immunotherapy action and their role in type 1 diabetes and pre-type 1 diabetes.\nList practical hurdles to T1D prevention and beta cell preservation.\nDiscuss the role of precision immunotherapy in type 1 diabetes and how other diseases do this better.\n\nSpeaker: \nLaura Jacobsen\, MD Assistant Professor \nAssociate Fellowship Program Director \nUniversity of Florida\, Gainesville\, FL \nRegister Here
URL:https://pedsendo.org/event/quarterly-education-webinar-state-of-immunotherapy-in-type-1-diabetes/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240315T120000
DTEND;TZID=America/New_York:20240315T130000
DTSTAMP:20240305T140730Z
CREATED:20240222T170411Z
LAST-MODIFIED:20240305T140730Z
UID:23572-1710504000-1710507600@pedsendo.org
SUMMARY:State of the Art; TREND SIG: Update on management of prolactinomas
DESCRIPTION:Session Type SIG: State of the Art: TREND SIG \nSession Title Update on management of prolactinomas \n Brief Description \nThe Consensus statement on Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement was published in 2023 in Nature Reviews Endocrinology. We would like to review the new guidelines with a focus on the section on prolactinomas in children and adolescents. In conjunction\, we would like to present challenging cases and go over management dilemmas as a group with a surgeon and endocrinologist present \nLearning Objectives  \n\nUnderstand new guidelines for treatment of prolactinoma in children and how to manage challenging cases\nUnderstand efficacy\, adverse effects and options for withdrawal of dopamine agonist therapy\, as well as indications for surgery in pediatric patients\nUnderstand the importance of genetic testing in pediatric prolactinoma\n\nSpeaker Name \nCraig Alter\, MD\, \nDirector of the Neuroendocrine Center in the Division of Endocrinology and Diabetes at Children’s Hospital Philadelphia. \nDr. Prashant Chittiboina\, \nPrincipal investigator of the Neurosurgery Unit for Pituitary and Inheritable Diseases at the Surgical Neurology Branch of the NINDS \nRegister Here
URL:https://pedsendo.org/event/state-of-the-art-trend-sig-update-on-management-of-prolactinomas/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240301T160000
DTEND;TZID=America/New_York:20240301T170000
DTSTAMP:20240222T165312Z
CREATED:20240222T165312Z
LAST-MODIFIED:20240222T165312Z
UID:23569-1709308800-1709312400@pedsendo.org
SUMMARY:SEED Webinar\, Pediatric Obesity: Current Management
DESCRIPTION:Title Pediatric Obesity: Current Management \nBrief Description \nObesity is a serious health issue affecting the pediatric population. It is a complex chronic disease that carries a significant risk of comorbidities. The prevalence of pediatric obesity has increased exponentially in recent years with prevalence increasing with age\, particularly in children from lower socioeconomic status. Lifestyle and behavioral changes lead to only modest improvement due to challenges and limitations in access. Lifestyle therapy outcomes are disappointing as a majority of adolescents with severe obesity\, despite repeated efforts\, are non-responders or achieve only a modest effect on weight. There is a need for intensive and non-stigmatizing treatment strategies including intensive health behavior and lifestyle treatment and pharmacotherapy for children and adolescents who require additional treatment options to address this public health issue. This talk will aim to address the effective treatment strategies to manage pediatric obesity. \n  \nLearning Objectives  \n\nReview AAP clinical practice guidelines on obesity\nDiscuss the shift in treatment approach to obesity\nDiscuss treatment options including medication and bariatric surgery\n\n  \nSpeaker  \nShruthi Arora MBBS Assistant Professor\, Division of Pediatric Endocrinology \nEmory University School of Medicine \nRegister Here
URL:https://pedsendo.org/event/seed-webinar-pediatric-obesity-current-management/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240129T160000
DTEND;TZID=America/New_York:20240129T170000
DTSTAMP:20240131T201317Z
CREATED:20240103T180406Z
LAST-MODIFIED:20240131T201317Z
UID:23393-1706544000-1706547600@pedsendo.org
SUMMARY:Quarterly Education Webinar: Islet auto-transplantation in children
DESCRIPTION:Monday\, January 29\, 2024 /4:00 pm – 5:00 pm EST \n  \nBrief Description: This talk will discuss islet cell auto-transplantation in children. \n Learning objectives: \n\nUnderstand the rationale for total pancreatectomy with islet auto-transplantation\nUnderstand the procedure of a total pancreatectomy with islet auto-transplantation\nBe familiar with islet function outcomes after islet auto-transplantation\n\nSpeaker: \nMelena Bellin\, MD\nProfessor\, Pediatric Endocrinology\, and Surgery\nCo-Director\, Total Pancreatectomy\, and Islet Auto-transplant Program\nAlbert D. and Eva J. Corniea Chair\nUniversity of Minnesota \n  \nView Recording
URL:https://pedsendo.org/event/quarterly-education-webinar-islet-auto-transplantation-in-children/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240119T160000
DTEND;TZID=America/New_York:20240119T170000
DTSTAMP:20240103T174633Z
CREATED:20240103T174621Z
LAST-MODIFIED:20240103T174633Z
UID:23388-1705680000-1705683600@pedsendo.org
SUMMARY:SEED: Hypoglycemia
DESCRIPTION:Brief Description \nThis talk will present an overview of the differential diagnosis of hypoglycemia\, digging deeper into hyperinsulinism\, the most common cause of persistent HI in infants and children. \nLearning Objectives  \n\nreview the differential diagnosis of hypoglycemia\nreview initial evaluation to determine cause of hypoglycemia\nreview the diagnosis and management of hyperinsulinism\n\nSpeaker  \nDr. Winnie Sigal \nPediatric Endocrinologist \nAssistant Professor of Pediatrics UPenn / CHOP
URL:https://pedsendo.org/event/seed-hypoglycemia/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240116T150000
DTEND;TZID=America/New_York:20240116T170000
DTSTAMP:20240104T191831Z
CREATED:20240103T174356Z
LAST-MODIFIED:20240104T191831Z
UID:23386-1705417200-1705424400@pedsendo.org
SUMMARY:PedsENDO365 - Career Pathways for Pediatric Endocrine Fellows
DESCRIPTION:Brief Description \nThis activity addresses the following key concepts: 1. Common viable career paths after fellowship training. 2. Importance of identifying what paths match values\, skills\, and interests 3. Role of networking in identifying mentors and job prospects. \nLearning Objectives  \n\nDescribe the career pathways available after endocrine fellowship\nIdentify what career pathway/s match your skills\, values\, and interests.\nEvaluate two possible career paths and the next steps needed via networking with professionals at various stages of a career in that track (clinician-scientist (basic/clinical)\, clinician-educator\, industry\, private practice)\n\nSpeakers:  \n\nPenelope Pauley\, MD\nAmy Levenson\, MD\, University of North Carolina at Chapel Hill\nMelissa Schoelwer\, MD\, University of Virginia Children’s Hospital\nNidhi Bansal\, Baylor College of Medicine\nMary Ellen Vajravelu\, MD MSHP\, UPMC Children’s Hospital of Pittsburgh
URL:https://pedsendo.org/event/pedsendo365-career-pathways-for-pediatric-endocrine-fellows-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231215T130000
DTEND;TZID=America/New_York:20231215T140000
DTSTAMP:20240103T174121Z
CREATED:20231113T164724Z
LAST-MODIFIED:20240103T174121Z
UID:23183-1702645200-1702648800@pedsendo.org
SUMMARY:SIG State of the Art Webinar: Bone SIG
DESCRIPTION:December 15: State of the Art – Bone \nTitle: Bone Stress Injuries and Stress Fractures in Adolescents and Young Adults: Natural History\, Evaluation and Management Strategies \nDescription: Review of risk factors and metabolic workup to consider in adolescents and young adults with bone stress injuries\, as well as management strategies. \nLearning Objectives  \n\nTo have a better understanding of common risk factors for bone stress injuries in active and athletic youth.\nTo have a better understanding of the natural history and typical healing trajectory of bone stress injuries in athletic youth and discuss when a metabolic or genetic bone disease workup is necessary.\nTo have a better understanding of treatment strategies for active and athletic youth with current or past bone stress injury history.\n\nSpeaker: \nDr. Aurelia Nattiv \nProfessor UCLA Departments of Family Medicine and Orthopedic Surgery \nDivision of Sports Medicine and Non-Operative Orthopedics \nDirector\, UCLA Bone Health Program \nDavid Geffen School of Medicine at UCLA Associate Team Physician\, \nUCLA Athletics Office
URL:https://pedsendo.org/event/sig-state-of-the-art-webinar-bone-sig/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231115T170000
DTEND;TZID=America/New_York:20231115T180000
DTSTAMP:20231116T172909Z
CREATED:20231006T144409Z
LAST-MODIFIED:20231116T172909Z
UID:23021-1700067600-1700071200@pedsendo.org
SUMMARY:New Advances in the Diagnosis and Management of Congenital Hyperinsulinism
DESCRIPTION:Description: \nA comprehensive review of diagnosis and management of congenital hyperinsulinism with emphasis on newly published international guidelines \nLearning objectives: \n\nDescribe the clinical manifestations\, genetics\, and natural history of congenital hyperinsulinism\nReview recent advances in the medical and surgical management of hyperinsulinism\nReview long-term outcomes and follow up of children with hyperinsulinism\n\nSpeaker: \nDiva D. De Leon-Crutchlow\, MD\, MSCE\nChief\, Division of Endocrinology and Diabetes\nDirector\, Congenital Hyperinsulinism Center\nChildren’s Hospital of Philadelphia\nProfessor of Pediatrics and Medicine\nPerelman School of Medicine at the University of Pennsylvania \n  \nView Recording
URL:https://pedsendo.org/event/new-advances-in-the-diagnosis-and-management-of-congenital-hyperinsulinism/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231113T160000
DTEND;TZID=America/New_York:20231113T170000
DTSTAMP:20231116T173107Z
CREATED:20230906T154318Z
LAST-MODIFIED:20231116T173107Z
UID:22871-1699891200-1699894800@pedsendo.org
SUMMARY:SIG State of the Art Webinar: Diabetes
DESCRIPTION:November 13: State of the Art – Diabetes \nTitle: Tips for Setting up a Multidisciplinary Clinic for Youth-onset Type 2 Diabetes \nSpeakers: Megan Kelsey\, MD\, Children’s Hospital Colorado\, University of Colorado School of Medicine\, Department of Pediatrics\, Helen Seagle\, RD\, Children’s Hospital Colorado\, Lauren Gulley\, PhD\, Children’s Hospital Colorado\, University of Colorado School of Medicine\, Department of Pediatrics\, Claudia Retamal-Munoz\, RN\, Children’s Hospital Colorado\, Mayra Baca\, PNP\, Children’s Hospital Colorado \nDescription: Webinar to be delivered by type 2 diabetes specialty care members\, including an endocrinologist\, NP\, RN-CDCES\, dietitian\, and psychologist who will each describe their role in delivering type 2 diabetes-focused care. Part of the goal of this webinar is to help providers understand how to leverage personnel who are currently focused on type 1 diabetes care to broaden their focus\, understanding that many centers do not have the resources to set up a separate type 2 diabetes program. \nView Recording
URL:https://pedsendo.org/event/sig-state-of-the-art-webinar-diabetes/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231107T150000
DTEND;TZID=America/New_York:20231107T170000
DTSTAMP:20231024T185559Z
CREATED:20230906T195248Z
LAST-MODIFIED:20231024T185559Z
UID:22899-1699369200-1699376400@pedsendo.org
SUMMARY:PedsENDO365: SMART goals for a Happy Professional Journey
DESCRIPTION:SMART goals for a Happy Professional Journey \nDescription: SMART goals for a Happy Professional Journey is a career development session that provides Pediatric Endocrine Fellows with tools and skills for SMART goal setting. This can be used by fellows to develop individualized learning plans with mentoring from their program faculty or program director. \nObjectives: \n\nBy end of this activity\, participants will have conducted an inventory of their Values\, Interests\, and Skills and available career paths.\nAssessed whether their interests and skills align with their values.\nDrafted a short-term (1-year) and a long-term (5-year) career goal.   Created I-SMART (Important\, Specific\, Measurable\, Accountable\, Realistic\, Time-limited) learning goals aligned with their career goals.\n\nSpeakers: \nAnshu Gupta\, MD\, MS\, Virginia Commonwealth University \nAmy Levenson\, MD\, University of North Carolina at Chapel Hill \nKanthi Bangalore Krishna\, University of Pittsburgh Medical Center \nNidhi Bansal\, Baylor College of Medicine \nAmit Lahoti\, Nationwide Children’s Hospital
URL:https://pedsendo.org/event/pedsendo365-smart-goals-for-a-happy-professional-journey/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231019T160000
DTEND;TZID=America/New_York:20231019T170000
DTSTAMP:20231024T184141Z
CREATED:20230906T191402Z
LAST-MODIFIED:20231024T184141Z
UID:22895-1697731200-1697734800@pedsendo.org
SUMMARY:State of the Art - Differences of Sex Development 
DESCRIPTION:October 19: State of the Art – Differences of Sex Development  \nTitle: Partial Androgen Insensitivity Syndrome (PAIS) – Commonly Suspected and Rarely Encountered \nSpeaker: Professor S. Faisal Ahmed\, MBChB\, MD\, MA\, FRCPCH\, Developmental Endocrinology Research Group\, University of Glasgow\, Royal Hospital for Sick Children \nDescription: PAIS is a very rare condition\, and each pediatric endocrinologist will probably not see more than a handful of cases in their local practice. However\, the condition typifies the challenges that are encountered in the diagnosis and long-term management of conditions that affect sex development. This talk will focus on PAIS and cover several aspects of its management across the patient journey from infancy to adulthood. \n  \nView Recording
URL:https://pedsendo.org/event/state-of-the-art-differences-of-sex-development/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230928T190000
DTEND;TZID=America/New_York:20230928T200000
DTSTAMP:20230906T173101Z
CREATED:20230906T172936Z
LAST-MODIFIED:20230906T173101Z
UID:22884-1695927600-1695931200@pedsendo.org
SUMMARY:Industry Sponsored Symposia – Early Identification and Effective Management of Hypercholesterolemia in Children
DESCRIPTION:Title: Early Identification and Effective Management of Hypercholesterolemia in Children \n\nDate: Thursday\, September 28 from 7:00 – 8:00 pm Eastern \nSession Description:\nThis interactive virtual symposium\, sponsored by Regeneron Medical Affairs\, with Don P. Wilson\, MD\, a renowned pediatric lipidologist\, will focus on diagnosing lipid disorders (including familial hypercholesterolemia) and managing treatment goals in children. \nSpeaker: Don P. Wilson\, MD\, FNLA\, Department of Pediatric Endocrinology and Diabetes\, Endowed Chair\, Pediatric Cardiovascular Health and Risk Prevention Program\, Cook Children’s Medical Center\, Fort Worth\, Texas \nModerator: Matt Ito\, PharmD\, Associate Director\, Medical Affairs\, Regeneron Pharmaceuticals\, Inc. \nLearning Objectives:\nAs a result of participating in this interactive virtual symposium\, learners should be able to: \n\nDiscuss the role of hypercholesterolemia and atherosclerosis in cardiovascular disease (CVD) beginning in childhood\nExplain why early identification and treatment of at-risk children can help prevent atherosclerosis and atherosclerosis-related events\, such as myocardial infarction and stroke during childhood and adulthood\nDescribe current recommendations and best clinical practices for cholesterol screening and setting treatment goals in children\n\n  \nSponsored by Regeneron Pharmaceuticals\, Inc.
URL:https://pedsendo.org/event/industry-sponsored-symposia-early-identification-and-effective-management-of-hypercholesterolemia-in-children/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230925T160000
DTEND;TZID=America/New_York:20230925T170000
DTSTAMP:20231024T190500Z
CREATED:20230906T181121Z
LAST-MODIFIED:20231024T190500Z
UID:22889-1695657600-1695661200@pedsendo.org
SUMMARY:SEED Program: Rickets? Acquired vs inherited?
DESCRIPTION:Speaker:\nNadia Merchant\, MD\,\nAssistant Professor of Pediatrics\nPediatric Endocrinologist and Geneticist \nDescription:\nRickets can vary from being asymptomatic to irritability\, growth retardation\, and sudden death. Nutritional-acquired rickets is the most common cause of rickets worldwide that we still see in the US. Let’s learn about preventing nutritional rickets! This presentation will review causes of acquired vs inherited rickets\, pathophysiology\, and importance of evaluating and treating promptly to avoid long term complications. \n  \nView Recording
URL:https://pedsendo.org/event/seed-program-rickets-acquired-vs-inherited/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230914T180000
DTEND;TZID=America/New_York:20230914T190000
DTSTAMP:20230906T173016Z
CREATED:20230906T172734Z
LAST-MODIFIED:20230906T173016Z
UID:22881-1694714400-1694718000@pedsendo.org
SUMMARY:Industry Sponsored Symposia - Achondroplasia a Multidisciplinary Conversation on Comprehensive Care
DESCRIPTION:Title: Achondroplasia a Multidisciplinary Conversation on Comprehensive Care \nDate: Thursday\, September 14 from 6:00 – 7:00pm EST \nSummary of Session:\nAchondroplasia (Ach)\, the most common skeletal dysplasia with disproportionate short stature\, is characterized by a number of medical\, functional\, and psychosocial challenges across the lifespan of an individual. Up until recently\, the treatment of the developmental complications of Ach involved only symptomatic management\, surgical intervention\, and lifelong follow-up care. An improved understanding of the molecular pathways involved in Ach has resulted in the development of new and emerging targeted therapies for this condition. These novel agents aim to restore bone growth and prevent many of the medical conditions associated with Ach. In this virtual live symposium\, an expert panel will address the complications associated with Ach\, current care recommendations\, strategies for coordination of care with specialists\, and new and emerging therapies for Ach.\n \nSpeakers: \n\nAndrew Dauber\, MD\, MMSc\, Chief of Endocrinology\, Children’s National Hospital\, Washington\, DC\nNadia Merchant\, MD\, Assistant Professor of Pediatrics\, Division of Endocrinology and Diabetes\, Children’s National Hospital\, Washington\, DC\nWilliam G. Mackenzie\, MD\, FRCS(c)\, FAAOS\, Chairman\, Department of Orthopedic Surgery\, Nemours Children’s Health\, Wilmington\, DE\n\n\n\nSponsored by BioMarin Pharmaceutical Inc.
URL:https://pedsendo.org/event/industry-sponsored-symposia-achondroplasia-a-multidisciplinary-conversation-on-comprehensive-care/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230913T120000
DTEND;TZID=America/New_York:20230913T130000
DTSTAMP:20231024T183859Z
CREATED:20230906T191129Z
LAST-MODIFIED:20231024T183859Z
UID:22892-1694606400-1694610000@pedsendo.org
SUMMARY:SIG State of the Art Webinar: Obesity
DESCRIPTION:September 13: State of the Art – Obesity \nTitle: Treating (Understanding) Complicated Obesity \nSpeaker: Gitanjali Srivastava\, MD\, FACP\, FAAP\, ABOM\, Vanderbilt University School of Medicine \nDescription: Join us to review novel therapeutics and treatment options for pediatric obesity and associated complications.
URL:https://pedsendo.org/event/sig-state-of-the-art-webinar-obesity/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230717T120000
DTEND;TZID=America/New_York:20230717T130000
DTSTAMP:20230703T135858Z
CREATED:20230206T153704Z
LAST-MODIFIED:20230703T135858Z
UID:22090-1689595200-1689598800@pedsendo.org
SUMMARY:Technology for Type 1 Diabetes in 2023 - New Options and Emerging Devices
DESCRIPTION:Speaker:\nGregory P. Forlenza\, MD\nAssociate Professor\nBarbara Davis Center\nUniversity of Colorado Anschutz Medical Campus \nDescription: With multiple new FDA approved T1D technology options in 2023\, the therapeutic landscape has become more diverse for patients and providers. We will discuss peer reviewed literature on current commercial options\, educate on device tuning\, and outline the near-term future of tech development. \nLearning Objectives:\n1. Differentiate current commercial technology options for type 1 diabetes therapy\n2. Understand therapeutic tuning for commercial Automated Insulin Delivery Systems\n3. Review emerging technology concepts and future directions \nRegister now!
URL:https://pedsendo.org/event/quarterly-webinar/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230602T150000
DTEND;TZID=America/New_York:20230602T170000
DTSTAMP:20230519T172902Z
CREATED:20230206T153629Z
LAST-MODIFIED:20230519T172902Z
UID:22088-1685718000-1685725200@pedsendo.org
SUMMARY:PedsENDO365
DESCRIPTION:Quality Improvement for Endocrinology Fellows \nJune 2\, 2023 / 3:00-5:00 PM ET \nObjectives: \n\nApply Plan-Do-Study Act Quality Improvement (QI) methodology using a real-world example.\nUnderstand utility of QI tools including: process map\, pareto chart\, fishbone diagram\, control/run chart\nDescribe how to find access to additional training / toolkits and review how QI projects can fulfill MOC Part 4 credits with the American Board of Pediatrics\n\nRegister Here
URL:https://pedsendo.org/event/pedsendo365-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230505T080000
DTEND;TZID=America/New_York:20230508T170000
DTSTAMP:20220602T160754Z
CREATED:20220602T160704Z
LAST-MODIFIED:20220602T160754Z
UID:21138-1683273600-1683565200@pedsendo.org
SUMMARY:2023 Annual Meeting
DESCRIPTION:
URL:https://pedsendo.org/event/2023-annual-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230414T160000
DTEND;TZID=America/New_York:20230414T170000
DTSTAMP:20230323T184928Z
CREATED:20230206T153546Z
LAST-MODIFIED:20230323T184928Z
UID:22086-1681488000-1681491600@pedsendo.org
SUMMARY:Lipid SIG: State of the Art Webinar
DESCRIPTION:Description: \nWithin the past several years\, there have been major therapeutic advances and new clinical trial data on the treatment of hypertriglyceridemia and its relationship to cardiovascular disease (CVD). New medications that either function within the liver to prevent protein production using anti-sense technologies and monoclonal antibodies that target proteins that block triglyceride clearance are in late stage clinical development. These drugs promise a treatment for triglyceride-induced pancreatitis. But will these triglyceride reductions affect development of CVD? Genetics implicates genes associated with defective plasma triglyceride catabolism with CVD. Thus far\, clinical triglyceride reduction trials using omega 3 fatty acids or fibrates have not provided clear answers. \nLearning Objectives: \n\nTo determine the genetic basis of familiar hyperchylomicronemia\nTo define the lifestyle\, dietary\, and pharmacologic factors and associated diseases that cause hypertriglyceridemia\nTo recognize the currently available medications for reduction of circulating triglyceride levels.\n\nSpeaker: \nIra J Goldberg\, MD\nClarissa and Edgar Bronfman\, Jr. Professor\nDirector\, Division of Endocrinology\, Diabetes and Metabolism
URL:https://pedsendo.org/event/lipid-sig-state-of-the-art-webinar/
CATEGORIES:SIG Webinar
END:VEVENT
END:VCALENDAR